Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
Condition(s) studied
Investigational drug(s) / intervention(s)
Sampling: Single-time sampling of respiratory virus-infected children
Study summary
Acute bronchiolitis is a common disease in children under the age of two, caused mainly by the respiratory syncytial virus (RSV). Furthermore, given the same medical history, it is still very difficult to predict the course and severity of the infection at the onset of symptoms, Some studies have highlighted the importance of the microbiota (intestinal, oral or nasopharyngeal) and of the immune response to RSV in children, We will include 80 children under 2 years old with hospitalized bronchiolitis and non-hospitalized bronchiolitis. Oral, nasal and stool samples will be taken to study the various microbiota in search of dysbiosis. A capillary blood sample will be taken for immune studies.
Eligibility
Primary outcome measure(s)
- Dysbiosis — Inclusion
comparison of the quantitative and qualitative composition of bacteria (alpha diversity, beta diversity, Shannon and Simpson index) in the digestive and nasopharyngeal microbiota
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| APHP, Antoine Béclère Hospital | Clamart | France | Recruiting |
| AP-HP,Raymond Poincaré Hospital | Garches | France | Recruiting |
| Réanimation médico-chirurgicale Necker | Paris | France | Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06161285 on ClinicalTrials.gov ↗ ← All trials in France